AAAS, October 14, 2014. One of the most pressing scientific issues facing Congress today is the risk that antibiotic resistance presents to human health. Unfortunately, there is an enormous gap between what the science tells us is needed and the Congressional approach.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Safety Advocates Seek Stronger Warnings On Chantix
Associated Press, October 8, 2014. Public safety advocates are asking the federal government to strengthen warnings on Pfizer’s anti-smoking drug Chantix, even as the drug maker prepares to argue that a bold-letter warning about psychiatric problems should be removed from the medicine’s label.
Read More »Health Officials Tell Medical Technology Group To ‘Prove It’
Modern Healthcare, October 8, 2014. “The thing that’s been missing from the model until now is the evidence,” said Diana Zuckerman, a researcher who has been critical of the Food and Drug Administration’s procedures for approving and monitoring medical devices.
Read More »Payment Reform Puts Medical-Device Industry On the Defensive
Modern Healthcare, October 7, 2014. Medical technology companies are warning that burgeoning pay-for-performance and risk-based reimbursement models will motivate providers to block access to clinically important innovations.
Read More »Medical Company May Be Falling Short Of Its Patient Safety Ideals
NPR, October 6, 2014. The Masima device company created a Patient Safety Movement Foundation but didn’t investigate reports that its devices harmed patients. “When a company refuses to respond in any way to the FDA other than to say that the FDA is wrong on every issue, that’s not very credible,” Zuckerman said. “Especially when users made complaints that the company’s product put patients at risk,” she said.
Read More »